Reports
Sale
Middle East and Africa In-vitro Diagnostics Market: By Product and Service: Reagents and Kits, Instruments, Software and Services; By Technology; By Application; By End Use; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments
Middle East and Africa In-vitro Diagnostics Market Outlook
The Middle East and Africa in-vitro diagnostics market is expected to grow at a CAGR of 3.2% during the period 2023-2028. Analysis of human samples offers physicians with vital information to properly diagnose, treat, and prevent illnesses. Several leading companies offer in-vitro diagnostic (IVD) solutions that deliver rapid, sensitive results while minimizing cost and complexity. Modern in-vitro diagnostics (IVDs) enable better diagnosis for prevention and management of infectious and chronic diseases. These factors are expected to drive market growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Likely to be Driven by Need for Efficient and Accurate Diagnostics, and Advancements in Technology
The Middle East and North Africa region is considered a manufacturer’s future high growth market for medical devices. Saudi Arabia, UAE, Turkey and Israel are considered large markets in terms of size and expenditure capacity.
In-vitro means ‘in glass’, indicating that these tests are generally carried out in test tubes and similar equipment, as against in vivo tests, that are performed in the body itself. In-vitro diagnostics may also be employed in precision medicine to determine patients likely to benefit from particular treatments or therapies. These in-vitro diagnostics could include next generation sequencing tests, which scan a person’s DNA to detect genomic variations. Some tests are carried out in a laboratory or other health professional settings, while others may be conducted by consumers at home. The tests themselves can be conducted on a wide range of instruments, varying from small, handheld tests to more complex laboratory instruments.
Introduction of New Technologies and Companies’ Efforts to Provide Better Solutions Expected to Drive Market Growth
Introduction of new technologies and growing penetration of private independent laboratories have led to significant progress in the clinical laboratory segment in the UAE and Saudi Arabia. Thus, there has been a distinct shift towards independent labs from hospital-based laboratories with advancements in technology. Such developments are likely to boost the Middle East and Africa in-vitro diagnostics market. Tests have also become more cost-effective. In 2022, AACC and Life Diagnostics partnered to relaunch AACC Middle East. The two-day conference and exposition would showcase world-class in-vitro diagnostic innovations and clinical laboratory best practices in Dubai, UAE.
Leading companies are offering solutions to enhance instrument performance. For example, Thermo Fisher offers AB Assurance Dx service plan exclusively for IVD instruments; the plan is devised to maintain instrument performance to make sure the availability of important instrument systems in the workflow. The AB Assurance Dx service plan would help keep laboratory operations running efficiently with planned maintenance, qualification services, proactive instrument monitoring (where available), and, in case instruments warrant service, a timely response. This service plan would suit locations such as clinical and IVD laboratories that rely on IVD instruments and the need to decrease production downtime risk.
In-vitro Diagnostics (IVD) and Point of Care Testing (POCT) Likely to Stimulate Market
In-vitro diagnostics (IVD) and point of care testing (POCT) are expected to witness significant growth. There has been considerable growth in demand for rapid, economical, easy-to-use POCT devices for infectious disease diagnostics in the UAE. Such developments are likely to boost the Middle East and Africa in-vitro diagnostics market. Other important areas with significant opportunities for growth include adoption of managed clinical services in the area’s hospitals, smart labs-as-a-service for automation of laboratory services and the need for next-generation sequencing testing for genetic testing.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Segmentation
By product and service, the market is segmented into:
- Reagents and Kits
- Instruments
- Software and Services
By technology, the market is classified into:
- Immunoassay/Immunochemistry
- Clinical Chemistry
- Molecular Diagnostics
- Haematology
- Microbiology
- Blood Glucose Self Monitoring
- Coagulation and Haemostasis
- Urinalysis
- Others
By application, the market is divided into:
- Infectious Diseases
- Diabetes
- Cardiology
- Oncology
- Autoimmune Diseases
- Nephrology
- Others
By end use, the market is classified into:
- Hospitals
- Laboratories
- Homecare
- Others
By country, the market is segmented into:
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Key Industry Players in the Market
The report presents a detailed analysis of the following key players in the Middle East and Africa in-vitro diagnostics market, looking into their capacity, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Becton, Dickinson and Company
- Beckman Coulter, Inc.
- Bio-Rad Laboratories, Inc.
- Surmodics IVD, Inc.
- Illumina, Inc.
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2022 |
| Historical Period | 2018-2022 |
| Forecast Period | 2023-2028 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product and Service |
|
| Breakup by Technology |
|
| Breakup by Application |
|
| Breakup by End Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Middle East and Africa
7 Opportunities and Challenges in the Market
8 Middle East and Africa In-Vitro Diagnostics Market Analysis
8.1 Key Industry Highlights
8.2 Middle East and Africa In-Vitro Diagnostics Historical Market (2018-2022)
8.3 Middle East and Africa In-Vitro Diagnostics Market Forecast (2023-2028)
8.4 Middle East and Africa In-Vitro Diagnostics Market by Product and Service
8.4.1 Reagents and Kits
8.4.1.1 Historical Trend (2018-2022)
8.4.1.2 Forecast Trend (2023-2028)
8.4.2 Instruments
8.4.2.1 Historical Trend (2018-2022)
8.4.2.2 Forecast Trend (2023-2028)
8.4.3 Software and Services
8.4.3.1 Historical Trend (2018-2022)
8.4.3.2 Forecast Trend (2023-2028)
8.5 Middle East and Africa In-Vitro Diagnostics Market by Technology
8.5.1 Immunoassay/Immunochemistry
8.5.1.1 Historical Trend (2018-2022)
8.5.1.2 Forecast Trend (2023-2028)
8.5.2 Clinical Chemistry
8.5.2.1 Historical Trend (2018-2022)
8.5.2.2 Forecast Trend (2023-2028)
8.5.3 Molecular Diagnostics
8.5.3.1 Historical Trend (2018-2022)
8.5.3.2 Forecast Trend (2023-2028)
8.5.4 Haematology
8.5.4.1 Historical Trend (2018-2022)
8.5.4.2 Forecast Trend (2023-2028)
8.5.5 Microbiology
8.5.5.1 Historical Trend (2018-2022)
8.5.5.2 Forecast Trend (2023-2028)
8.5.6 Blood Glucose Self Monitoring
8.5.6.1 Historical Trend (2018-2022)
8.5.6.2 Forecast Trend (2023-2028)
8.5.7 Coagulation and Haemostasis
8.5.7.1 Historical Trend (2018-2022)
8.5.7.2 Forecast Trend (2023-2028)
8.5.8 Urinalysis
8.5.8.1 Historical Trend (2018-2022)
8.5.8.2 Forecast Trend (2023-2028)
8.5.9 Others
8.6 Middle East and Africa In-Vitro Diagnostics Market by Application
8.6.1 Infectious Diseases
8.6.1.1 Historical Trend (2018-2022)
8.6.1.2 Forecast Trend (2023-2028)
8.6.2 Diabetes
8.6.2.1 Historical Trend (2018-2022)
8.6.2.2 Forecast Trend (2023-2028)
8.6.3 Cardiology
8.6.3.1 Historical Trend (2018-2022)
8.6.3.2 Forecast Trend (2023-2028)
8.6.4 Oncology
8.6.4.1 Historical Trend (2018-2022)
8.6.4.2 Forecast Trend (2023-2028)
8.6.5 Autoimmune Diseases
8.6.5.1 Historical Trend (2018-2022)
8.6.5.2 Forecast Trend (2023-2028)
8.6.6 Nephrology
8.6.6.1 Historical Trend (2018-2022)
8.6.6.2 Forecast Trend (2023-2028)
8.6.7 Others
8.7 Middle East and Africa In-Vitro Diagnostics Market by End Use
8.7.1 Hospitals
8.7.1.1 Historical Trend (2018-2022)
8.7.1.2 Forecast Trend (2023-2028)
8.7.2 Laboratories
8.7.2.1 Historical Trend (2018-2022)
8.7.2.2 Forecast Trend (2023-2028)
8.7.3 Homecare
8.7.3.1 Historical Trend (2018-2022)
8.7.3.2 Forecast Trend (2023-2028)
8.7.4 Others
8.8 Middle East and Africa In-Vitro Diagnostics Market by Country
8.8.1 Saudi Arabia
8.8.2 United Arab Emirates
8.8.3 Nigeria
8.8.4 South Africa
8.8.5 Others
9 Regional Analysis
9.1 Saudi Arabia
9.1.1 Historical Trend (2018-2022)
9.1.2 Forecast Trend (2023-2028)
9.2 United Arab Emirates
9.2.1 Historical Trend (2018-2022)
9.2.2 Forecast Trend (2023-2028)
9.3 Nigeria
9.3.1 Historical Trend (2018-2022)
9.3.2 Forecast Trend (2023-2028)
9.4 South Africa
9.4.1 Historical Trend (2018-2022)
9.4.2 Forecast Trend (2023-2028)
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 Becton, Dickinson and Company
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Beckman Coulter, Inc.
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Bio-Rad Laboratories, Inc.
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Surmodics IVD, Inc.
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 Illumina, Inc.
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Others
12 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Middle East and Africa In-Vitro Diagnostics Market: Key Industry Highlights, 2018 and 2028
2. Middle East and Africa In-Vitro Diagnostics Historical Market: Breakup by Product and Services (USD Million), 2018-2022
3. Middle East and Africa In-Vitro Diagnostics Market Forecast: Breakup by Product and Services (USD Million), 2023-2028
4. Middle East and Africa In-Vitro Diagnostics Historical Market: Breakup by Technology (USD Million), 2018-2022
5. Middle East and Africa In-Vitro Diagnostics Market Forecast: Breakup by Technology (USD Million), 2023-2028
6. Middle East and Africa In-Vitro Diagnostics Historical Market: Breakup by Application (USD Million), 2018-2022
7. Middle East and Africa In-Vitro Diagnostics Market Forecast: Breakup by Application (USD Million), 2023-2028
8. Middle East and Africa In-Vitro Diagnostics Historical Market: Breakup by End Use (USD Million), 2018-2022
9. Middle East and Africa In-Vitro Diagnostics Market Forecast: Breakup by End Use (USD Million), 2023-2028
10. Middle East and Africa In-Vitro Diagnostics Historical Market: Breakup by Country (USD Million), 2018-2022
11. Middle East and Africa In-Vitro Diagnostics Market Forecast: Breakup by Country (USD Million), 2023-2028
12. Middle East and Africa In-Vitro Diagnostics Market Structure.
Key Questions Answered in the Report
The market is projected to grow at a CAGR of 3.2% between 2023 and 2028.
The major drivers of the market include the growing penetration of private independent laboratories, growth in demand for point of care testing, adoption of managed clinical services in the area’s hospitals, and the need for next-generation sequencing testing for genetic testing.
The growing need for efficient and accurate diagnostics and advancements in technology are the key industry trends propelling the market's growth.
The major countries in the industry are Saudi Arabia, United Arab Emirates, Nigeria, and South Africa, among others.
The various products and services in the Middle East and Africa in-vitro diagnostics market are reagents and kits, instruments, software and services.
Based on technology, the market is segmented into immunoassay/immunochemistry, clinical chemistry, molecular diagnostics, haematology, microbiology, blood glucose self monitoring, coagulation and haemostasis, and urinalysis, among others.
The major applications of the market are infectious diseases, diabetes, cardiology, oncology, autoimmune diseases, and nephrology, among others.
The end-uses of the market are hospital, laboratories, and homecare, among others.
The major players in the industry are Becton, Dickinson and Company, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Surmodics IVD, Inc., and Illumina, Inc., among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 2199
$1799
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$3199$2999-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
$4199$3999-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$5199$4999-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER